UNLOCKING THE FUTURE OF MATERNAL HEALTH: PLATELET INDICES AS PREDICTORS OF PRE-ECLAMPSIA
DOI:
https://doi.org/10.22159/ijcpr.2023v15i6.4005Keywords:
Pre-eclampsia, Platelet count, Mean platelet volume, Platelet distribution width, Plateletcrit, Predictive markers, Pregnancy complications, Maternal health, Fetal outcomesAbstract
Objective: Pre-eclampsia is a serious complication of pregnancy, posing significant risks to maternal and fetal health. Predictive indicators for this condition are essential for early diagnosis and management. Platelet indices, including platelet count (PC), platelet distribution width (PDW), mean platelet volume (MPV), and platelet crit (PCT), are potential biomarkers for pre-eclampsia due to their association with coagulation abnormalities. This study aims to investigate the utility of platelet indices in predicting pre-eclampsia.
Methods: The study was conducted at Kamla Nehru State Hospital for Mother and Child, Shimla, Himachal Pradesh, from March 1, 2021, to February 28, 2022. Normotensive pregnant women with singleton pregnancies after 20 w of gestation were included, and those with pre-existing conditions were excluded. Platelet indices were measured throughout pregnancy, and patients were categorized based on the development and severity of pre-eclampsia. Data were analyzed using SPSS-PC-25, and statistical tests were performed to determine the significance of platelet index variations.
Results: The study reveals significant differences in platelet indices between normotensive and preeclampsia (PE) patients. PE patients exhibited elevated mean platelet volume (MPV), decreased platelet count, and increased platelet distribution width (PDW) compared to normotensive individuals. Notably, MPV increased significantly in PE, preceding blood pressure elevation. Platelet count decreased significantly in severe PE cases. Receiver Operating Characteristic (ROC) curve analysis demonstrated the potential of platelet count and MPV as predictors for PE. These findings underscore the relevance of platelet indices in PE diagnosis and highlight their potential utility as early markers of this hypertensive disorder during pregnancy.
Conclusion: Platelet indices, particularly platelet count, MPV, and PDW, hold promise as early markers for predicting and monitoring pre-eclampsia. Monitoring platelet indices alongside blood pressure could aid in assessing the severity and progression of the condition, contributing to improved maternal and fetal outcomes. Further research in this area is warranted to refine predictive models and enhance clinical utility.
Downloads
References
American College of Obstetricians and Gynecologists. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2020;135(3):e237-60.
American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia. Obstetrics and Gynecology. 2019;133(1):e1-e25.
Poon LCY, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53(5):812-8. doi: 10.1161/hypertensionaha.108.127977.
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130-7. doi: 10.1053/j.semperi.2009.02.010.
Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-4. doi: 10.1126/science.1111726.
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-99.
Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243-9. doi: 10.1161/01.HYP.0000188408.49896.c5.
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-44. doi: 10.1016/S0140-6736(10)60279-6.
Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2002;102(1):181-92.
Karumanchi SA, Granger JP. Preeclampsia and pregnancy-related hypertensive disorders. Hypertension. 2016;67(2):238-42. doi: 10.1161/hypertensionaha.115.05024.
Amaral LM, Palei AC. Platelets: emerging contributors of preeclampsia. World J Obstet Gynecol. 2017;6(1):24-31.
Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational-age. J Matern Fetal Neonatal Med. 2008;21(5):279-87. doi: 10.1080/14767050802034545.
Harsem NK, Staff AC, He L. Platelet activation in pre-eclampsia. Hypertens Pregnancy. 2003;22(2):121-31.
Braekke K, Holthe MR, Harsem NK, Staff AC. Calibrated automated thrombin generation in normal pregnancy and pregnancy complicated by preeclampsia. Thromb Res. 2004;113(5):371-6.
Ozdemir R, Yildirim E, Yilmaz S, Yildirim A, Korkmaz M, Oltulu F. The role of platelet parameters in the diagnosis of preeclampsia. Pregnancy Hypertens. 2017;9:9-13.
Goto S, Kojima Y, Nishikawa T, Koyamada R. Platelet size reflects disease severity in patients with myelodysplastic syndromes. Leuk Res. 2000;24(12):1043-8.
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-58. doi: 10.1172/JCI17189.
Salahuddin S, Lee Y, Vadnais ML, Sachs BP. Karpatkin S. Elevation of platelet activation and aggregation in pregnancy: quantitation by flow cytometry. Thromb Haemost. 1997;78(04):991-6.
Svensson J, Siegbahn A, Bergqvist D, Bergqvist A. Tissue factor pathway inhibitor and other endothelium‐dependent haemostatic factors in healthy men and women: relation to gender. Blood Coagul Fibrinolysis. 1999;10(7):389-94.
Yoneyama Y, Sawa R, Suzuki S, Otsubo Y, Takeishi Y, Atarashi H. Usefulness of mean platelet volume as a biomarker for long-term outcomes after acute myocardial infarction. Am J Cardiol. 2016;118(3):338-44.
Shen F, Li M. The relationship between platelet indices and preeclampsia. Pak J Med Sci. 2018;34(1):136-40.
Gonzalez Quintero VH, Kathiresan AS. The role of platelet‐to‐lymphocyte ratio as a predictor of maternal and fetal morbidity in preeclampsia. J Clin Ultrasound. 2008;36(3):159-64.
Published
How to Cite
Issue
Section
Copyright (c) 2023 SONAKSHI SHARMA, ANOOP SHARMA, GEETIKA GUPTA SYAL
This work is licensed under a Creative Commons Attribution 4.0 International License.
